TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule

Fabio Manzo1, Angela Nebbioso, Marco Miceli

  • 1Dipartimento di Patologia Generale, Seconda Università degli Studi di Napoli, Italy.

Insights

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces cancer cell death and plays a role in immunity. This review explores TRAIL

Area of Science:

  • Molecular biology
  • Immunology
  • Cancer research

Background:

  • Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a key mediator of programmed cell death.
  • TRAIL interacts with death receptors (TRAIL-R1/R2) and decoy receptors (TRAIL-R3/R4), with differential expression in normal versus cancer cells.
  • TRAIL's expression in the lymphoid system suggests a significant role in innate immunity.

Purpose of the Study:

  • To provide a comprehensive review of TRAIL's biological functions and therapeutic potential.
  • To analyze TRAIL gene structure, regulation, protein folding, tissue expression, and molecular signaling pathways.
  • To evaluate TRAIL's application in cancer treatment, both as a monotherapy and in combination therapies.

Main Methods:

  • Literature review and analysis of existing research on TRAIL.
  • Examination of TRAIL gene structure, protein characteristics, and signaling mechanisms.
  • Assessment of preclinical and clinical data regarding TRAIL-based cancer therapies.

Main Results:

  • TRAIL preferentially induces apoptosis in cancer cells.
  • TRAIL exhibits a crucial role in the innate immune system.
  • Differential expression of TRAIL receptors in normal and cancerous tissues is a key aspect of its function.

Conclusions:

  • TRAIL holds significant promise as an anticancer therapeutic agent.
  • Combination therapies involving TRAIL or TRAIL-targeting drugs may enhance treatment efficacy.
  • Further research into TRAIL signaling and its receptors is warranted for optimizing cancer treatment strategies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...